Piper Sandler Reiterates Overweight on Nutanix, Raises Price Target to $75
Piper Sandler analyst James Fish reiterates Nutanix (NASDAQ:NTNX) with a Overweight and raises the price target from $60 to $75.
Read original at benzingaStocks · News reference
Nutanix shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 sales guidance above estimates.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 27, 2026, 11:59 AM
- Checked
- Aug 27, 2026, 11:59 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Why Nutanix Stock Is Soaring Today
Nutanix stock surged 9.87% after reporting Q4 2026 results that beat analyst expectations with $757.1 million in revenue (16% YoY growth) and $0.60 diluted EPS versus $0.49 expected. The company also generated strong free cash flow of $277.6 million and provided optimistic fiscal 2027 guidance of $3.18-$3.23 billion in revenue and $850-$950 million in free cash flow.
Read original at the-motley-foolRBC Capital Maintains Outperform on Nutanix, Raises Price Target to $90
RBC Capital analyst Matthew Hedberg maintains Nutanix (NASDAQ:NTNX) with a Outperform and raises the price target from $84 to $90.
Read original at benzingaSynopsys Posts Upbeat Q3 Results, Joins Okta, Veeva Systems, Crowdstrike And Other Big Stocks Moving Higher On Thursday
U.S. stocks mostly higher, Nasdaq up 1%. Synopsys Inc. reports strong Q3 results and raises outlook. Other gainers include Okta, Veeva, Salesforce, Ooma, Crowdstrike, Sailpoint, Hyperliquid, Tenable, Palo Alto Networks, and Zscaler.
Read original at benzinga